Brensocatib

CAS: 1802148-05-5

Ref. 3D-BB177302

Información del producto

• Nombre: Brensocatib
• Sinónimos: AZD 7986(S)-N-((S)-1-Cyano-2-(4-(3-methyl-2-oxo-2,3-dihydrobenzo[d]oxazol-5-yl)phenyl)ethyl)-1,4-oxazepane-2-carboxamide
• Marca: Biosynth
• Descripción: Rensocatib is a reversible inhibitor of DPP-1, also known as cathepsin C, which is a peptidase involved in the activation of neutrophil, an elastase-like serine protease in lung tissue. Brensocatib is an oral drug used to treat infections of the airways (lungs) that are characterised by a permanent enlargement and presenting symptoms such as, coughing and greater mucus production (bronchiectasis). Alternative names of brensocatib are INS-1007 and AZD7986.

Propiedades químicas

• Peso molecular: 420.46 g/mol
• Fórmula: C₂₃H₂₄N₄O₄
• Pureza: Min. 95 Area-%
• Color/Forma: Powder